Literature DB >> 9596270

Aberrant crypt foci in human colons: distribution and histomorphologic characteristics.

B Shpitz1, Y Bomstein, Y Mekori, R Cohen, Z Kaufman, D Neufeld, M Galkin, J Bernheim.   

Abstract

Aberrant crypt foci (ACF) are one of the earliest putative preneoplastic, and in some cases, neoplastic lesions in human colons. These microscopic lesions, identified on methylene blue-stained mucosa with a low-power-magnification microscope, are thought to be closely related to the earliest steps in multistage colonic tumorigenesis. We investigated the distribution pattern and histomorphological features of ACF in 74 patients with sporadic colorectal cancer. The distribution pattern shows a slightly higher prevalence with older age. The prevalence of the ACF in sigmoid colon was significantly higher in patients with colorectal cancer as compared with patients with benign colonic diseases. Also, significantly more ACF were detected in distal parts of the large bowel (descending, sigmoid colon, and rectum) than in proximal parts. Of 42 microdissected lesions, 12 were dysplastic and 30 were hyperplastic foci. The average size of dysplastic lesions was significantly larger than hyperplastic foci. More apoptotic bodies were found in dysplastic lesions. These lesions also showed an upward expansion of proliferative compartment and higher proliferation indices expressed as proliferating cell nuclear antigen-labeling index. Lymphoid follicles were frequently observed in the base of both hyperplastic and dysplastic foci (40% and 66.6%, respectively). The coincidence of lymphoid follicles was 2.5 to 8 times higher than expected. These features may be related to further progression of selected ACF during colorectal tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9596270     DOI: 10.1016/s0046-8177(98)90062-4

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  27 in total

1.  Precancerous ACF induction affects their regional distribution forsaking oxidative stress implication in 1,2-dimethylhydrazine-induced colon carcinogenesis model.

Authors:  Hichem Moulahoum; Andras-Laszlo Nagy; Bahia Djerdjouri; Simona Clichici
Journal:  Inflammopharmacology       Date:  2017-07-21       Impact factor: 4.473

Review 2.  Accumulation of aberrant DNA methylation during colorectal cancer development.

Authors:  Eiji Sakai; Atsushi Nakajima; Atsushi Kaneda
Journal:  World J Gastroenterol       Date:  2014-01-28       Impact factor: 5.742

Review 3.  Aberrant crypt foci in colorectal carcinogenesis. Cell and crypt dynamics.

Authors:  L Roncucci; M Pedroni; F Vaccina; P Benatti; L Marzona; A De Pol
Journal:  Cell Prolif       Date:  2000-02       Impact factor: 6.831

4.  Effect of concomitant polyethylene glycol and celecoxib on colonic aberrant crypt foci and tumors in F344 rats.

Authors:  Khoa Do; Graham F Barnard
Journal:  Dig Dis Sci       Date:  2005-07       Impact factor: 3.199

5.  CpG island methylation in aberrant crypt foci of the colorectum.

Authors:  Annie On-On Chan; Russell R Broaddus; Patrick S Houlihan; Jean-Pierre J Issa; Stanley R Hamilton; Asif Rashid
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

Review 6.  Aberrant crypt foci as microscopic precursors of colorectal cancer.

Authors:  Lei Cheng; Mao-De Lai
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

7.  Aberrant crypt focus and fragile histidine triad protein in sporadic colorectal carcinoma.

Authors:  Kim Vaiphei; Aruna Rangan; Rajinder Singh
Journal:  World J Gastrointest Oncol       Date:  2012-12-15

Review 8.  Aberrant crypt foci as precursors in colorectal cancer progression.

Authors:  Frank A Orlando; Dongfeng Tan; Juan D Baltodano; Thaer Khoury; John F Gibbs; Victor J Hassid; Bestoun H Ahmed; Sadir J Alrawi
Journal:  J Surg Oncol       Date:  2008-09-01       Impact factor: 3.454

9.  Reliability and accuracy of the endoscopic appearance in the identification of aberrant crypt foci.

Authors:  Akshay K Gupta; Paul Pinsky; Christopher Rall; Matthew Mutch; Sarah Dry; David Seligson; Robert E Schoen
Journal:  Gastrointest Endosc       Date:  2009-06-21       Impact factor: 9.427

10.  Suppressive effect of aspirin on aberrant crypt foci in patients with colorectal cancer.

Authors:  B Shpitz; E Klein; G Buklan; D Neufeld; A Nissan; H R Freund; M Grankin; J Bernheim
Journal:  Gut       Date:  2003-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.